NCT06506344 Syncing Screening and Services for Suicide Prevention Across Health and Jail Systems
| NCT ID | NCT06506344 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Henry Ford Health System |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 5,250 participants |
| Start Date | 2024-06-24 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5,250 participants in total. It began in 2024-06-24 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to harmonize jail release record data with electronic health record data in order to connect patients to an evidence-based suicide prevention and clinical care pathway upon jail release.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Released from jail between February 2021 and July of 2028 * Had a prior primary care visit or behavioral health visit at a participating health system in the past 3 years Exclusion Criteria: * Does not currently reside in the same state as the study site (i.e.- Michigan, Minnesota) * Would require a translator to participate in the research according to EHR data * Previously requested to be excluded from research
Contact & Investigator
Brian Ahmedani, PhD, MSW
PRINCIPAL INVESTIGATOR
Henry Ford Health
Frequently Asked Questions
Who can join the NCT06506344 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06506344 currently recruiting?
Yes, NCT06506344 is actively recruiting participants. Contact the research team at dwisnie2@hfhs.org for enrollment information.
Where is the NCT06506344 trial being conducted?
This trial is being conducted at Detroit, United States, Bloomington, United States.
Who is sponsoring the NCT06506344 clinical trial?
NCT06506344 is sponsored by Henry Ford Health System. The principal investigator is Brian Ahmedani, PhD, MSW at Henry Ford Health. The trial plans to enroll 5,250 participants.